Published in Hematology Week, October 9th, 2006
Study 1: Low-density lipoprotein from type 1 diabetes patients is more susceptible to homocysteinylation than low-density lipoproteins from nondiabetic individuals.
According to recent research from Italy, "Homocysteine (Hcy) is an independent risk factor for cardiovascular disease (CVD). Individuals with type 1 and type 2 diabetes are more susceptible to the effects of homocysteine than nondiabetic subjects. The interaction between homocysteine-thiolactone (Hcy-thiolactone), a reactive product of Hcy, and low-density lipoproteins (LDL) induces the formation of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.